Showing results (11-20 of 385) with videos related to
Sort By:
Pageof 39
Current Opinion in Neurology|August 17, 2021
Amyotrophic lateral sclerosis is a systemic disease: peripheral contributions to inflammation-mediated neurodegenerationStanley H Appel, David R Beers, Weihua ZhaoParkinsonism & Related Disorders|November 23, 2013
Role of iron in UPS impairment model of Parkinson's diseaseWeidong LeCurrent Opinion in Rheumatology|October 22, 2003
Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosisEricka P Simpson, Albert A Yen, Stanley H AppelCurrent Opinion in Neurology|July 27, 2018
Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesisJason R Thonhoff, Ericka P Simpson, Stanley H AppelExpert Review of Proteomics|February 1, 2006
2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseasesEssam A Sheta, Stanley H Appel, Ira L GoldknopfTrends in Immunology|November 3, 2009
T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?Stanley H Appel, David R Beers, Jenny S HenkelNeurosurgery|November 15, 2005
Incidence and characteristics of spinal decompression surgery after the onset of symptoms of amyotrophic lateral sclerosisDaniel Yoshor, Arnett Klugh, Stanley H Appel, et al.Muscle & Nerve|September 13, 2006
Predictability of disease progression in amyotrophic lateral sclerosisAdam Czaplinski, Albert A Yen, Ericka P Simpson, et al.Archives of Neurology|August 16, 2006
Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?Adam Czaplinski, Albert A Yen, Ericka P Simpson, et al.Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|September 5, 2009
Microglia in ALS: the good, the bad, and the restingJenny S Henkel, David R Beers, Weihua Zhao, et al.Pageof 39